SMC Global DistribusiAdvancing Care. Empowering Clinicians.
EN
Bahasa IndonesiaEnglish
Journals & Clinical Evidence

Efficacy and Safety of Non-Ablative Dual Wavelength Diode Laser Therapy for Genitourinary Syndrome of Menopause: A Single-Center Prospective Study

Curated research to understand technology benefits, comparisons, and limitations, prioritizing studies that identify devices or brands in our portfolio.

Brochures & MediaJournals & Clinical EvidenceSolutions by Specialty
All journalsUrologyObstetrics & GynecologyOrthopedics & PainSurgery & ProctologyRespiratory & Sleep MedicinePlastic & Reconstructive SurgeryDermatology & Aesthetics

1 publication

Brand / device family2024 · Vitale SG et al.

LEONARDO for GSM: follow-up to six months

Efficacy and Safety of Non-Ablative Dual Wavelength Diode Laser Therapy for Genitourinary Syndrome of Menopause: A Single-Center Prospective Study
Advances in Therapy 41:4617–4627

Prospective pilot study · 22 postmenopausal women · Single centre · Three sessions · No control group

Findings: At six months, VHIS increased from 12 to 19.27. Vaginal dryness scores fell from 7.72 to 3.72; burning and dyspareunia also improved.

Points to consider: A small study without a comparator. Before–after results cannot separate intervention effects from other factors or establish superiority or long-term safety.

Device & relevance: The abstract names a LEONARDO dual-wavelength diode laser. The offered variant and configuration must be matched to the full publication.

Read publication ↗Overview link

DOI: 10.1007/s12325-024-03004-7